Aurobindo Pharma

quarterly
yearly
ParticularsDec '24Mar '25Jun '25Sep '25Dec '25
Revenue8,1368,5177,9738,4068,834
Expenses6,9387,1506,7697,1327,430
EBITDA1,7351,9271,7081,7991,961
EBIT1,3181,4501,3051,3711,431
Profit Before Tax1,2001,3351,2071,2761,339
Net Profit845.57902.83824.20848.13909.80
Financial Ratios
Operating Profit Margin22.00%22.60%21.95%21.86%22.04%
Net Profit Margin10.72%10.78%10.58%10.30%11.10%
Earning Per Share (Diluted)14.5615.5614.2014.6115.67
Dividends Per Share0.000.004.000.000.00